Sandoz AG
1,747Patents
132Active
1,747Granted
48Portfolio score
Filing activity: Sep 23, 1969 → May 25, 2024 · 41 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4166800A | Processes for preparation of microspheres | Emerging Cross-Sectional Technologies | 310 | Expired |
| US5342625A | Pharmaceutical compositions comprising cyclosporins | Human Necessities | 289 | Expired |
| US5273758A | Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms | Human Necessities | 247 | Expired |
| US4384975A | Process for preparation of microspheres | Performing Operations; Transporting | 201 | Expired |
| US4388307A | Galenical compositions | Emerging Cross-Sectional Technologies | 189 | Expired |
| US5639480A | Sustained release formulations of water soluble peptides | Human Necessities | 179 | Expired |
| US5665772A | O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants | Human Necessities | 170 | Expired |
| US4325863A | Benzofuranone or indolinone compounds useful as stabilizers for organic materials | Chemistry; Metallurgy | 148 | Expired |
| US4356167A | Liposome drug delivery systems | Human Necessities | 133 | Expired |
| US4338244A | Benzofuran(2)one or indolin(2)one compounds useful as stabilizers for organic materials | Chemistry; Metallurgy | 127 | Expired |
| US5538739A | Sustained release formulations of water soluble peptides | Chemistry; Metallurgy | 119 | Expired |
| US5639724A | Cyclosporin galenic forms | Human Necessities | 118 | Expired |
| US5403593A | Melt granulated compositions for preparing sustained release dosage forms | Human Necessities | 112 | Expired |
| US4671883A | Fluid loss control additives for oil-based well-working fluids | Emerging Cross-Sectional Technologies | 97 | Expired |
| US5403868A | Capsaicin derivatives | Chemistry; Metallurgy | 95 | Expired |
| US5561149A | Use of certain imidazol carbazols in treating stress-related manic-depressive disorders | Chemistry; Metallurgy | 90 | Expired |
| US5536310A | Cementitious compositions containing fly ash | Emerging Cross-Sectional Technologies | 89 | Expired |
| US4003377A | Patient ventilator | Human Necessities | 86 | Expired |
| US4061142A | Apparatus for controlling blood flow | Human Necessities | 86 | Expired |
| US4634664A | Process for the production of human mono-clonal antibodies | Chemistry; Metallurgy | 83 | Expired |
| US4117118A | Organic compounds | Emerging Cross-Sectional Technologies | 82 | Expired |
| US5039680A | New use of 5HT-3 antagonists in preventing or reducing dependency on dependency-inducing agents | Human Necessities | 80 | Expired |
| US5284826A | 0-hydroxyethyl and acyloxyethyl derivatives of [ser].sup.8 cyclosporins | Human Necessities | 76 | Expired |
| US5356896A | Stabilized pharmaceutical compositions comprising an HMG-CoA reductase inhibitor compound | Human Necessities | 76 | Expired |
| US4108985A | Dihydrocyclosporin C | Emerging Cross-Sectional Technologies | 74 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.